Talk:Immunoediting

Medicine: Hematology-oncology Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by the Hematology-oncology task force.

Phases

Very strange separating phases 2 and 3. Overall it sounds like the tumour evolves cells that can escape immunosurveillance so there is no essential difference between the phases (other than changes in amount of tumour). Perhaps the refs explain the definitions of the phases better. - Rod57 (talk) 14:54, 14 March 2016 (UTC)[reply]